Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$567,013
-$110,603 QoQ
Shares Held
4,488
-7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,327
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EVERPAR ADVISORS LLC holds $12,411,314 across 10 Drug Manufacturers - General names. GILD ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,780 | $3,334,415 | |
| 2 | JNJ |
Johnson & Johnson
|
12,152 | $3,086,243 | |
| 3 | ABBV |
AbbVie Inc.
|
6,863 | $1,727,005 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,417 | $1,210,084 | |
| 5 | AMGN |
Amgen Inc
|
2,218 | $803,182 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
4,488 | $567,013 | |
| 7 | AZN |
Astrazeneca PLC
|
2,894 | $548,760 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,874 | $511,319 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $567,013 | 4,488 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $677,616 | 4,862 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $538,460 | 4,387 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $383,283 | 3,453 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $333,940 | 3,012 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||